Same Drug Class

Ipilimumab vs Trastuzumab

Ipilimumab vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Ipilimumab and Trastuzumab.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Trastuzumab β€” 28 days.

Chemical Properties

Type: Ipilimumab β€” Antibody; Trastuzumab β€” Antibody.